EUVIMEDEUVIMED entdecken
Crossref

WDR4 promotes colorectal cancer progression by activating the GSK3β/β-catenin pathway

Hongyu Wang, Liyang Liang, Yanfei Wang, Xuan Zhong, Chao Zhang, Zhipeng Liu, Jinzhong Liu, Wanning Hu iD

Biochemistry and Cell Biology · 01.01.2025 · 103 · 1-12

DOI: 10.1139/bcb-2024-0168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, erschienen am 01.01.2025. Verfasst von Hongyu Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Medical University, Shijiazhuang, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Glycogen Synthase Kinase 3 beta, beta Catenin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WD repeat domain 4 (WDR4) has been reported to promote tumor metastasis in various cancers. However, its precise function in colorectal cancer (CRC) has not been reported yet. Herein, the expression pattern of WDR4 in CRC was determined by analyzing Gene Expression Omnibus datasets (GSE110225, GSE127069, GSE156355, and GSE184093) and GEPIA online dataset. In vitro and in vivo experiments, including CCK-8, colony formation, flow cytometry, wound healing, transwell assays, and xenograft mouse models, were used to investigate the role of WDR4 in CRC. Firstly, data from Kaplan–Meier database showed that high expression of WDR4 was associated with the poor prognosis of CRC patients. Then, upregulation of WDR4 was confirmed in clinical CRC tissues. In vitro functional experiments suggested that overexpression of WDR4 promoted cell proliferation, migration, and invasion, while knockdown of WDR4 has the opposite effects. Also, the oncogenic role of WDR4 was also verified in in vivo experiments. CO-IP-LC/MS analysis uncovered that glycogen synthase kinase 3β (GSK3β) is the central protein that binds to WDR4. Mechanistically, WDR4 activated the β-catenin pathway by promoting GSK3β phosphorylation. This study demonstrates that WDR4 promotes CRC progression through activating GSK3β/β-catenin pathway, indicating that WDR4 might be a potential therapeutic target for CRC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGlycogen Synthase Kinase 3 betabeta CateninHumansAnimalsMiceCell ProliferationCell MovementMice, NudeDisease ProgressionFemaleMaleMice, Inbred BALB CCell Line, TumorGene Expression Regulation, NeoplasticSignal Transduction

Stichwörter der Autor:innen

GSK3β/β-cateninWDR4colorectal cancer

Substanzen

Glycogen Synthase Kinase 3 betabeta CateninGSK3B protein, humanCTNNB1 protein, human

Autor:innen und Institutionen

  • Hebei Medical University, Shijiazhuang, P.R. China.
  • Department of Surgical Oncology, Tangshan Gongren Hospital, Tangshan, P.R. China.
  • Department of Oncology, Tangshan Gongren Hospital, Tangshan, P.R. China.
  • Department of Gastrointestinal Surgery, Tangshan Central Hospital, Tangshan, P.R. China.

ORCID-Profile: Wanning Hu

Zitieren

APA

Wang, H., Liang, L., Wang, Y., Zhong, X., Zhang, C., Liu, Z., Liu, J., & Hu, W. (2025). WDR4 promotes colorectal cancer progression by activating the GSK3β/β-catenin pathway. Biochemistry and Cell Biology, 103, 1-12. https://doi.org/10.1139/bcb-2024-0168

Vancouver

Wang H, Liang L, Wang Y, Zhong X, Zhang C, Liu Z, et al. WDR4 promotes colorectal cancer progression by activating the GSK3β/β-catenin pathway. Biochemistry and Cell Biology. 2025;103:1-12. doi:10.1139/bcb-2024-0168

BibTeX
@article{Wang2025,
  author = {Wang, Hongyu and Liang, Liyang and Wang, Yanfei and Zhong, Xuan and Zhang, Chao and Liu, Zhipeng and Liu, Jinzhong and Hu, Wanning},
  title = {WDR4 promotes colorectal cancer progression by activating the GSK3β/β-catenin pathway},
  journal = {Biochemistry and Cell Biology},
  year = {2025},
  volume = {103},
  pages = {1--12},
  doi = {10.1139/bcb-2024-0168}
}
Kostenlos starten →